SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-21-000045
Filing Date
2021-04-14
Accepted
2021-04-14 16:03:24
Documents
15
Period of Report
2021-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnca-20210412.htm   iXBRL 8-K 34386
7 gnca-20210412_g1.jpg GRAPHIC 16581
  Complete submission text file 0001457612-21-000045.txt   222721

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnca-20210412.xsd EX-101.SCH 2462
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gnca-20210412_cal.xml EX-101.CAL 747
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gnca-20210412_def.xml EX-101.DEF 1693
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnca-20210412_lab.xml EX-101.LAB 25298
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnca-20210412_pre.xml EX-101.PRE 13227
8 EXTRACTED XBRL INSTANCE DOCUMENT gnca-20210412_htm.xml XML 10972
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 21825735
SIC: 2836 Biological Products, (No Diagnostic Substances)